Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

114.49

-3.83 (-3.24%)

At close: Jul 31, 2026, 4:00 PM EDT

116.76

+2.27 (1.98%)

After-hours: Jul 31, 2026, 7:54 PM EDT

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	111.04	120.5	127.67	135.55	66.33	77.62
Short-Term Investments	197.16	251.66	255.67	232.67	365.34	145.92
Cash & Short-Term Investments	308.2	372.15	383.33	368.22	431.67	223.54
Cash Growth	-9.94%	-2.92%	4.10%	-14.70%	93.11%	-49.28%
Accounts Receivable	76.92	59.79	53.98	41.12	31.06	27.63
Other Receivables	-	-	-	14	14	-
Total Trade Receivables	76.92	59.79	53.98	55.12	45.06	27.63
Inventory	13.19	12.87	12.41	7.73	6.1	4.99
Other Current Assets	41.37	40.66	21.88	27.56	16.42	10.32
Total Current Assets	439.68	485.46	471.6	458.64	499.25	266.46
Net Property, Plant & Equipment	11.99	6.47	8.01	0.32	1.78	1.52
Long-Term Investments	236.45	160.27	219.83	57.18	4.95	112.28
Other Long-Term Assets	200.58	184.44	141.11	105.39	77.45	43.5
Total Assets	888.7	836.65	840.55	621.52	583.43	423.76
Accounts Payable	14.91	40.44	15.38	17.4	11.98	6.91
Accrued Expenses	136.98	124.56	124.57	86.96	59.37	40.11
Current Portion of Leases	1.92	1.08	0.83	0.15	1.14	0.53
Total Current Liabilities	153.8	166.09	140.77	104.51	72.49	47.54
Long-Term Leases	7.5	5.02	6.11	-	-	-
Other Long-Term Liabilities	21.62	17.74	14.08	10.31	9.1	0.41
Total Long-Term Liabilities	29.12	22.76	20.19	10.31	9.1	0.41
Total Liabilities	182.93	188.85	160.96	114.81	81.59	47.95
Common Stock	0.14	0.14	0.14	0.13	0.13	0.13
Treasury Stock	-998.01	-966.59	-696.17	-635.08	-456.15	-410.41
Additional Paid-in Capital	1,049	968.6	832.11	738.52	662.34	591.35
Accumulated Other Comprehensive Income	0.44	2.26	-0.22	0.61	-0.87	-0.23
Retained Earnings	654.61	643.39	543.74	402.53	296.39	194.97
Shareholders' Equity	705.78	647.81	679.59	506.71	501.84	375.81
Total Liabilities & Equity	888.7	836.65	840.55	621.52	583.43	423.76
Total Debt	9.42	6.11	6.94	0.15	1.14	0.53
Net Cash (Debt)	298.78	366.05	376.4	368.07	430.53	223.01
Net Cash Growth	-10.98%	-2.75%	2.26%	-14.51%	93.05%	-49.10%
Net Cash Per Share	2.59	3.05	3.32	3.29	3.71	1.77
Book Value	705.78	647.81	679.59	506.71	501.84	375.81
Book Value Per Share	6.11	5.40	5.99	4.53	4.33	2.98
Tangible Book Value	705.78	647.81	679.59	506.71	501.84	375.81
Tangible Book Value Per Share	6.11	5.40	5.99	4.53	4.33	2.98

SEC Filings: 10-K · 10-Q